Published in Br J Cancer on April 01, 1999
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer (2000) 1.26
Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate (2010) 1.09
Response to influenza immunisation during treatment for cancer. Arch Dis Child (2001) 1.02
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One (2011) 1.00
Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res (2005) 0.95
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer. Oncologist (2012) 0.90
Immunogenicity of influenza vaccine in colorectal cancer patients. Cancer Res Treat (2013) 0.82
Influenza vaccination in cancer patients undergoing systemic therapy. Clin Med Insights Oncol (2014) 0.81
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients. Oncologist (2012) 0.81
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study. Br J Cancer (2011) 0.81
Virosome presents multimodel cancer therapy without viral replication. Biomed Res Int (2013) 0.80
Humoral and cellular immune responses to influenza vaccination in children with cancer receiving chemotherapy. Oncol Lett (2012) 0.76
Vaccination recommendations for the hematology and oncology and post-stem cell transplant populations. J Adv Pract Oncol (2012) 0.75
Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Neuro Oncol (2014) 0.75
Practical review of immunizations in adult patients with cancer. Hum Vaccin Immunother (2015) 0.75
Immunogenicity of Influenza Vaccination in Patients With Cancer. Am J Clin Oncol (2015) 0.75
Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy. Hum Vaccin Immunother (2016) 0.75
Influenza among hospitalized adults with leukemia. Clin Infect Dis (1997) 1.68
Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine (1989) 1.35
Effectiveness of influenza vaccination policy at targeting patients at high risk of complications during winter 1994-5: cross sectional survey. BMJ (1997) 1.33
Influenza immunization of adult patients with malignant diseases. Ann Intern Med (1977) 1.28
Antibody response to influenza immunization in adult patients with malignant disease. Cancer (1979) 1.11
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill (2012) 7.96
Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet (1997) 5.22
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill (2012) 4.96
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res (2004) 3.95
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother (2003) 3.90
Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A (1988) 3.34
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol (2003) 2.92
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer (2005) 2.71
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Mortality in Barrett's esophagus: three decades of experience at a single center. Endoscopy (2012) 2.67
Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG (2012) 2.57
Adverse impact of surgical site infections in English hospitals. J Hosp Infect (2005) 2.51
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill (2010) 2.49
Alternate splicing produces a novel cyclin D1 transcript. Oncogene (1995) 2.48
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33
Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect (2003) 2.33
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer. Br J Cancer (2000) 2.30
Detection of influenza A(H3N2) virus in children with suspected mumps during winter 2014/15 in England. Euro Surveill (2015) 2.19
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer (1987) 2.18
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer. J Clin Oncol (2005) 2.17
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands. Eur J Epidemiol (1999) 2.06
Venous leg ulcers: a prognostic index to predict time to healing. BMJ (1992) 2.05
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect (2004) 2.05
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer (1987) 1.97
Genetic predisposition to human lung cancer. Br J Cancer (1986) 1.94
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. Ann Oncol (2011) 1.88
Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ (2011) 1.85
Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill (2011) 1.84
Advances in electronic surveillance for healthcare-associated infections in the 21st Century: a systematic review. J Hosp Infect (2013) 1.79
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol (1994) 1.79
Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology (2006) 1.77
Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill (2011) 1.76
Volunteers or victims: patients' views of randomised cancer clinical trials. Br J Cancer (1995) 1.70
Patients' interpretation of symptoms as a cause of delay in reaching hospital during acute myocardial infarction. Heart (2000) 1.67
Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother (2006) 1.64
Adherence to medication regimens: updating a complex medical issue. Med Care Rev (1992) 1.64
Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma. J Clin Oncol (2003) 1.62
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol (1995) 1.61
Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health (2009) 1.48
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46
Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br J Cancer (1986) 1.45
Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill (2015) 1.44
Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect (2007) 1.44
Duration of operation as a risk factor for surgical site infection: comparison of English and US data. J Hosp Infect (2006) 1.42
Cleanyourhands Campaign: a critique of the critique. J Hosp Infect (2007) 1.42
Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill (2008) 1.39
Emergence of influenza A H1N2 reassortant viruses in the human population during 2001. Virology (2002) 1.39
Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand (1999) 1.38
Bradyphrenia and parkinsonism. Age Ageing (1994) 1.38
Women's attitudes to cervical smear testing. N Z Med J (1990) 1.38
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer (1996) 1.38
A phase I study of intravenous bryostatin 1 in patients with advanced cancer. Br J Cancer (1993) 1.38
Influenza types and patient population. Lancet (1995) 1.37
O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. Cancer Res (1991) 1.34
The significance of cagA(+) Helicobacter pylori in reflux oesophagitis. Gut (2001) 1.34
Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. J Natl Cancer Inst (2000) 1.33
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill (2013) 1.32
Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill (2014) 1.32
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand (2011) 1.31
Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma. Cancer Res (1989) 1.31
Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood (2000) 1.29
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. Br J Cancer (1998) 1.29
Population estimates of persons presenting to general practitioners with influenza-like illness, 1987-96: a study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands. Epidemiol Infect (2000) 1.28
ACTH precursors characterize the ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1994) 1.27
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer (2000) 1.26
Influenza surveillance in England and Wales: October 1999 to May 2000. Commun Dis Public Health (2000) 1.24
Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect (2010) 1.23
Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis. Eur J Cancer (1992) 1.22
Fat, fish, fish oil and cancer. Br J Cancer (1996) 1.21
A decade of change: tuberculosis in England and Wales 1988-98. Arch Dis Child (2003) 1.20
Can syndromic surveillance data detect local outbreaks of communicable disease? A model using a historical cryptosporidiosis outbreak. Epidemiol Infect (2006) 1.19
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma. Br J Cancer (1977) 1.18
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol (2004) 1.17
An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J Virol Methods (1997) 1.17
Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations. Clin Exp Immunol (1981) 1.16
A method for following human lymphocyte traffic using indium-111 oxine labelling. Clin Exp Immunol (1981) 1.15
The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales. Int J STD AIDS (1999) 1.15
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer (1988) 1.14
Linking syndromic surveillance with virological self-sampling. Epidemiol Infect (2007) 1.14
Upper abdominal lymphadenopathy as first presentation of relapse, identified by ultrasonography, in patients treated for small cell (oat cell) bronchogenic carcinoma. Br J Dis Chest (1985) 1.14
Stereotyping the smoker: adolescents' appraisals of smokers in film. Tob Control (2004) 1.13
An estimate of the contribution of HIV infection to the recent rise in tuberculosis in England and Wales. Thorax (2002) 1.12
Large outbreak of isoniazid-monoresistant tuberculosis in London, 1995 to 2006: case-control study and recommendations. Euro Surveill (2011) 1.11
Addisonian crisis presenting with a normal short tetracosactrin stimulation test. Postgrad Med J (1992) 1.11
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11
Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK. Epidemiol Infect (2011) 1.09
Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. Eur J Cancer (1991) 1.08
Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrob Chemother (1998) 1.08
Parents' attitude towards the second dose of measles, mumps and rubella vaccine: a case-control study. Commun Dis Public Health (2003) 1.08
Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang (2004) 1.07
Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int Immunol (2001) 1.05
How should general practitioners investigate suspected urinary tract infection? Variations in laboratory-confirmed bacteriuria in South West England. Commun Dis Public Health (2004) 1.05